Anti-fitc Microbeads
Anti-fitc Microbeads - Related Videos
01:58
Studying the Permeation of FITC and FITC-Ferritin through an In Vitro Blood-Brain Barrier Model
0 Views •
2025
This video demonstrates a method to study permeation through an in vitro blood-brain barrier (BBB) model using astrocytes and endothelial cells on a membrane insert, with free FITC and FITC-loaded ferritin. FITC-ferritin bound to receptors on endothelial cells and crossed the membrane barrier to the lower chamber while free FITC showed restricted permeation and remained in the upper chamber.
05:54
Microbead Implantation in the Zebrafish Embryo
0 Views •
Cited by 8 •
2015
The zebrafish is an excellent model system for genetic and developmental studies. Bead implantation is a valuable tissue manipulation technique that can be used to interrogate developmental mechanisms by introducing alterations in local cellular environments. This protocol describes how to perform microbead implantation in the zebrafish embryo.
02:56
FITC-Dextran Feeding: A Method to Quantify Intestinal Permeability in C. elegans
0 Views •
2023
This video introduces a method of to visualize and measure the integrity of the C. elegans intestine lumen by feeding worms FITC-labeled dextran. The example protocol shows the assay done with 3,3’-diindolylmethane (DIM)-treated and pathogen-fed worms.
03:08
Fabrication of Amyloid-Beta-Releasing Polymer Microbeads for Modeling Alzheimer's Disease
0 Views •
2025
This video demonstrates a method for fabricating polymer microbeads that encapsulate neurotoxic amyloid-beta-secreting cells. The cell-polymer suspension is processed through a microbead fabrication device, with polymer gelation achieved via calcium cross-linking, forming spherical microbeads around the cells. The polymer allows cell proliferation while allowing controlled, long-term amyloid-beta release, simulating its accumulation in Alzheimer's disease.
05:51
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
0 Views •
Cited by 18 •
2016
Here, we describe a simple method of intracerebroventricular and intravascular injection of viral particles or fluorescent microbeads into the neonatal mouse brain. The localization pattern of the virus and nanoparticles could be detected by microscopic evaluation or by in situ hybridization.
FAQs
The anti-FITC antibody on each microbead recognizes fluorescein groups attached to a primary antibody or other probe. This creates a secondary magnetic label without requiring the original targeting reagent to carry a magnetic particle. As a result, researchers can use FITC-based immunostaining to direct magnetic capture of selected cells or biological targets.
Indirect labeling separates target recognition from magnetic handling. A primary antibody or probe first identifies the desired biological target through its specificity, while the anti-FITC microbead supplies the magnetic handle by binding the attached fluorescein. This arrangement supports flexible immunostaining workflows and can be applied after defined populations have been fluorescently labeled.
Retention depends on whether the target carries a FITC-containing antibody or probe that can recruit anti-FITC microbeads. Once the magnetic complex forms, material associated with that complex can be held in a magnetic field, commonly within a separation column. Unretained material provides a corresponding fraction for depletion or comparative analysis.
The same magnetic interaction can be used for different separation goals. Researchers may retain FITC-labeled targets to positively select them, remove labeled cells to deplete a population, or use the resulting fractions to enrich a defined subset. The chosen strategy depends on whether the experiment requires recovery of labeled material, removal of unwanted cells, or compositionally improved samples.
A typical workflow begins by labeling cells or other biological targets with a FITC-conjugated primary antibody or probe. Anti-FITC microbeads are then allowed to bind the fluorescein groups, forming magnetic complexes. The sample is passed through a magnetic separation setup, commonly a column, so retained and unretained fractions can be collected for subsequent analysis.
In immunology and infection research, this approach can isolate or remove defined immune-cell populations after immunostaining and can help examine pathogen-associated targets. The separated material may then support immune-cell profiling, functional studies, or molecular analyses. Its value lies in combining fluorescence-guided target identification with magnetic fractionation in a single workflow.